Side-by-side financials for EOLS and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EOLS | NVS |
|---|---|---|
| Market cap | - | $293.12 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $297.18M | - |
| Net income (latest FY) | -$51.64M | - |
| Net margin | -17.4% | - |
| SEC filings | 543 | 947 |
Full pages: Evolus, Inc. and Novartis AG, or browse the full rankings.